1.Prevalence of anxiety and depression among PCOS patients seen in a tertiary government hospital using the hospital anxiety and depression scale – English/Pilipino version (HADS/HADS-P).
Diana J. Cupino-Arcinue ; Ma Jesusa Banal-Silao
Acta Medica Philippina 2024;58(11):29-38
Background:
PCOS is a common gynecologic disorder and recent studies have found that they are more prone in developing depression and anxiety compared to the general population. The Hospital Anxiety and Depression Scale (HADS) is a popular and simple self-administered instrument reliable for detecting states of anxiety and depression. Using this simple screening tool, it may lead to the identification of such mental disorders that may warrant timely psychiatric referral.
Objectives:
We aim to determine the prevalence of anxiety and depression among PCOS patients using the HADS-P questionnaire. We also aim to determine association between depression & anxiety and disease characteristics.
Methods:
This is a cross-sectional study using convenience sampling of PCOS patients >18 years old in Philippine General Hospital. The HADS-P, a self-administered rating scale with independent subscales for anxiety and depression, was administered to the participants after securing consent. A cut–off score of >8 points on either of the depression and anxiety subscale was used to determine their respective prevalence. Logistic regression analysis was used to determine the association of clinical variables with anxiety or depression.
Results:
A total of 253 patients with PCOS were recruited. On the basis of a HADS-P score of >8.0 per category, the prevalence of PCOS patients who were suggestive to have anxiety was 46.25% (n: 117, 95% CI: 39.98-52.60%), while 9.09% (n: 23, 95% CI: 5.85-13.33%) of them were suggestive to have depression. Crude logistic regression identified presence of depression, infertility, impaired glucose tolerance and prominent acne as predictors of anxiety; whereas low parity, hirsutism and presence of anxiety were predictors of depression. Adjusted logistic regression identified only presence of depression and infertility were significant predictors of anxiety (n: 116, LR χ2 (5): 15.46, p<0.01); while presence of anxiety increase the odds of depression by 2 to 13 fold, it was not statistically significant (n: 116, LR χ2 (5): 9.79, p: 0.08).
Conclusion
There is a high prevalence of anxiety and depression among PCOS patients. The factors that were seen to be significantly associated with the development of anxiety were the presence of depression, impaired glucose tolerance, infertility and prominent acne, while for the development of depression were the presence of anxiety, hirsutism and low parity. Screening for anxiety and depression is of paramount importance and physicians should be vigilant for the need of possible psychiatric intervention.
Anxiety
;
Depression
;
Hads
;
4-amino-4'
;
-hydroxylaminodiphenylsulfone
;
Polycystic Ovary Syndrome
2.Prevalence of depression and anxiety symptoms and their correlation with posttraumatic growth among HIV-positive patients enrolled in an HIV/AIDS clinic at a tertiary hospital from July 2015 to October 2015.
The Philippine Journal of Psychiatry 2017;39(1):14-22
OBJECTIVES: This study evaluated the prevalence of anxiety, depression, and posttraumatic growth (positive psychological change as a result of the struggle with highly challenging life circumstances) among patients with HIV/AIDS as well as determine the correlation between these variables alongside select sociodemographic variables.
METHODOLOGY: Fifty eight patients enrolled in an HIV/AIDS clinic at a tertiary hospital were selected via convenience sampling and asked to complete a sociodemographic questionnaire, the Posttraumatic Growth Inventory (PTGI) and the Hospital Anxiety and Depression Scale (HADS) from July to October 2015.
RESULTS: Ninety three percent of the participants reported moderate to high levels of posttraumatic growth, with a mean score of 4.70 (SD = 0.86). 20.7% (11.2 - 33.4, CL=95%) of patients screened positive for depression while 55.2% (41.5 - 68.3, CL=95%) of patients screened positive for anxiety. A statistically significant negative corellation was demonstrated between posttraumatic growth and depression (r=-0.29, p-value= 0.027) but not for anxiety (r=.027, p-value= 0.118).
CONCLUSION: There is a high prevalence of patients in the sample that exhibit depression and anxiety symptoms. Despite this, most patients report a capacity to experience positive changes in the aftermath of a life-threatening, chronic, and stigmatizing illness, correlating with a decrease in depressive symptomatology. As such, initiatives promoting posttraumatic growth are valuable in the comprehensive care for patients afflicted with HIV/AIDS.
Human ; Male ; Female ; Depression ; Prevalence ; Tertiary Care Centers ; Acquired Immunodeficiency Syndrome ; 4-amino-4'-hydroxylaminodiphenylsulfone ; Anxiety ; Depressive Disorder ; Anxiety Disorders
3.A validation of the hospital anxiety and depression scale (HADS) in the medically-ill.
de Guzman Ma. Lourdes Rosanna E.
Acta Medica Philippina 2013;47(3):53-62
The underdiagnosis of depression and anxiety in the medical complications, improve compliance to treatment, and facilitate the "appropriate" use of health care resources.
OBJECTIVES: To determine the prevalence of depression and/or anxiety in the in-patient medically ill and to validate the Hospital Anxiety and Depression Scale (HADS) for Filipinos.
METHODS: To aid clinicians, the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report questionnaire was validated in this cross-sectional study of 710 medically ill in-patients, to be able to determine how well it identified depression and anxiety against the criterion of a diagnostic psychiatric interview and to determine the optimal cut-off score of the HADS for Filipinos with the use of the Receiver Operating Characteristics (ROC).
RESULTS: The prevalence of depression was 26.9% anxiety was 14.3%, and the 'mixed diagnosis' of both was 13.7% among the medically-ill. The overall prevalence was 54.9%. The results showed that the optimal cut-off score for the HADS/ HADS-P is a score of 11, with a sensitivity of 75%, specificity of 70% and PPV of 75%.
CONCLUSION: The HADS/ HADS-P will provide clinicians with a reliable, valid and practical screening tool for identifying the two most common clinical problems in the medically ill, depression and anxiety. The HADS/ HADS-P can serve as a guide for clinicians towards the diagnosis of depression and anxiety, but it cannot be the sole basis for diagnosis.
Human ; Male ; Female ; Aged ; Middle Aged ; Adult ; Depression ; Self Report ; 4-amino-4'-hydroxylaminodiphenylsulfone ; Anxiety ; Anxiety Disorders ; Depressive Disorder ; Sensitivity And Specificity